Literature DB >> 14975190

Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.

Jonathan L Bramson1, Natalie Grinshtein, Robert A Meulenbroek, John Lunde, Dayantha Kottachchi, Ian A Lorimer, Bernard J Jasmin, Robin J Parks.   

Abstract

Adenoviruses (Ads) have shown great utility as vectors for the delivery of genes to mammalian cells, partly because of their ability to infect a wide range of different cell types independent of the replicative state of the cell. However, Ads do not transduce mature muscle efficiently because of low levels of the natural viral primary receptor, the coxsackie virus and adenovirus receptor, on the surface of adult muscle cells. In this study, we have addressed whether incorporation of polylysine [p(K)] or arginine-glycine-aspartic acid (RGD) placed in the H-I loop of the adenoviral fiber protein can improve helper-dependent Ad vector (hdAd) transduction of mature muscle cells. We show that incorporation of the p(K) motif into the fiber of early region 1 (E1)-deleted Ad results in enhanced transduction of undifferentiated and differentiated C2C12 cells relative to a virus, containing a wild-type fiber (12- and 21-fold enhancement, respectively). Incorporation of the RGD motif resulted in only a 60-70% increase in transduction efficiency in these cells. The two fiber modifications were then incorporated into helper viruses for use in the Cre-lox system for generating hdAd, and the resulting retargeted Ad vectors, which encoded the beta-galactosidase reporter gene (beta-Gal), demonstrated enhanced transduction of C2C12 cells in culture. Although hdAdpK also showed enhanced infection of mature mouse muscle in vivo, hdAdRGD did not. All hdAd vectors elicited only minor anti-Ad immune responses, compared with an E1-deleted control vector, but each vector elicited strong anti-beta-Gal immunoreactivity. Our results demonstrate that hdAd with modified cell tropism can be generated efficiently and, in the case of polylysine-modified hdAd, can lead to improved transduction of adult muscle cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975190     DOI: 10.1089/104303404772679986

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  DNA genome size affects the stability of the adenovirus virion.

Authors:  Adam C Smith; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

2.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 3.  Helper-dependent adenoviral vectors in experimental gene therapy.

Authors:  Alicja Józkowicz; Józef Dulak
Journal:  Acta Biochim Pol       Date:  2005-08-04       Impact factor: 2.149

4.  Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.

Authors:  Kathy L Poulin; Robert M Lanthier; Adam C Smith; Carin Christou; Milagros Risco Quiroz; Karen L Powell; Ryan W O'Meara; Rashmi Kothary; Ian A Lorimer; Robin J Parks
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

5.  Capsid-modified adenoviral vectors for improved muscle-directed gene therapy.

Authors:  Kilian Guse; Masataka Suzuki; Gautam Sule; Terry K Bertin; Henna Tyynismaa; Sofia Ahola-Erkkilä; Donna Palmer; Anu Suomalainen; Philip Ng; Vincenzo Cerullo; Akseli Hemminki; Brendan Lee
Journal:  Hum Gene Ther       Date:  2012-08-13       Impact factor: 5.695

6.  Helper-Dependent Adenoviral Vectors.

Authors:  Amanda Rosewell; Francesco Vetrini; Philip Ng
Journal:  J Genet Syndr Gene Ther       Date:  2011-10-29

7.  Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.

Authors:  Francesco Vetrini; Philip Ng
Journal:  Viruses       Date:  2010-09-03       Impact factor: 5.818

8.  Retinal transduction profiles by high-capacity viral vectors.

Authors:  A Puppo; G Cesi; E Marrocco; P Piccolo; S Jacca; D M Shayakhmetov; R J Parks; B L Davidson; S Colloca; N Brunetti-Pierri; P Ng; G Donofrio; A Auricchio
Journal:  Gene Ther       Date:  2014-07-03       Impact factor: 5.250

9.  Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells.

Authors:  Bratati Saha; Robin J Parks
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing.

Authors:  Jonathan M Haldeman; Amanda E Conway; Michelle E Arlotto; Dorothy H Slentz; Deborah M Muoio; Thomas C Becker; Christopher B Newgard
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.